DHEA-S: The Adrenal Androgen That Fades With Age

DHEA-S in plain language, briefly defined

DHEA-S (dehydroepiandrosterone sulfate) is the sulfated, stable form of DHEA, produced almost entirely by the adrenal zona reticularis via sulfation of DHEA by the enzyme SULT2A1. Its long half-life and minimal diurnal variation make it the preferred marker for adrenal androgen status — a reliable, slowly moving signal of how much androgen precursor your adrenal glands are putting out.

The biology behind your DHEA-S number

The core loop: the pituitary releases ACTH, the adrenals respond by producing DHEA, and SULT2A1 sulfates it to DHEA-S for stable circulation. Peripheral tissues then desulfate DHEA-S back to DHEA and convert it downstream into androstenedione, testosterone, or estrogens depending on local enzyme activity — a universal precursor that each tissue builds from as needed.

DHEA-S does not measure total androgen load. It measures adrenal precursor output specifically; ovarian and testicular androgens are separate contributors and require their own markers to assess.

Chronic psychological stress can shift the cortisol/DHEA-S ratio by suppressing adrenal DHEA output through ACTH down-regulation. The ratio itself — not just DHEA-S alone — is the signal for physiological wear: low DHEA-S alongside high cortisol reflects a system skewed toward catabolism rather than balanced adrenal output.

Age shapes the entire picture. Levels climb around puberty (adrenarche), peak in early adulthood, then decline gradually across decades. Men generally run higher than women. In postmenopausal women, DHEA-S becomes a key precursor for local estrogen production in tissues such as bone and brain, making its decline particularly relevant in that life stage.

Low, normal, and high DHEA-S explained

Because DHEA-S declines continuously across the lifespan and differs by sex, every result must be read against age- and sex-matched reference intervals — not a single universal number. Labs use different assay methods and may report different ranges; a value that looks low on one platform may fall within range on another. Use trends and clinical context alongside any single result.

Normal DHEA-S

A result within the reference interval means your adrenal androgen output falls in the expected range for your age and sex. Men generally run higher than women across all age groups. Postmenopausal women may have particularly low absolute values as the adrenal gland becomes the primary estrogen precursor source; this can still be within a normal age-matched range. Because the decline is continuous, a value that was comfortably mid-range at 35 may sit near the lower boundary at 55 — both can be normal for their respective reference windows.

High DHEA-S

Elevated DHEA-S often reflects increased adrenal androgen production. Polycystic ovary syndrome (PCOS) can feature higher DHEA-S when the adrenal glands contribute to the androgen load, though not everyone with PCOS has this pattern. Some adrenal tumors produce excess androgens; when levels are very high and persistent, clinicians evaluate that possibility alongside imaging and other labs. Congenital adrenal hyperplasia can push DHEA-S up via enzyme bottlenecks that shunt precursors into androgen pathways. Over-the-counter DHEA supplementation raises DHEA-S substantially. Because ACTH stimulates adrenal androgen production, anything driving ACTH up may pull DHEA-S with it. A single elevated result that normalizes on repeat testing may reflect assay variation or a transient physiologic shift — trends and corroborating markers are more informative than any single datapoint.

Low DHEA-S

Low DHEA-S can reflect reduced adrenal reserve. Common contributors include natural aging, adrenal insufficiency, hypopituitarism (low ACTH drive), and chronic glucocorticoid therapy that suppresses adrenal output. Combined oral contraceptives and oral estrogens can reduce DHEA-S as part of their broader effect on steroid metabolism. Symptoms don't always align predictably — some people with low DHEA-S report low energy, reduced libido, or lower stress tolerance; others feel no different. A single low result can reflect lab method differences or recent illness; repeating the test, checking related hormones, and pairing the data with the full clinical picture gives a more reliable read.

What can shift DHEA-S independent of true biology

Several factors can move a DHEA-S result without reflecting a meaningful change in underlying adrenal function:

• Glucocorticoid medications suppress ACTH and reliably lower DHEA-S; the effect is dose- and duration-dependent.
• Combined oral contraceptives and oral estrogens reduce adrenal androgens as part of their broader effect on steroid metabolism.
• Exogenous DHEA supplements raise DHEA-S reliably and quickly; over-the-counter availability means supplementation is a common and easily overlooked confounder.
• High-dose biotin can distort some immunoassay results, producing falsely elevated or suppressed values depending on assay design.
• Severe caloric restriction lowers steroid output as the body deprioritizes anabolic and reproductive processes under energy scarcity.
• Chronic psychological stress shifts the cortisol/DHEA-S ratio by suppressing adrenal DHEA output via ACTH down-regulation; the ratio change may be more informative than the absolute DHEA-S value alone.
• Assay method matters for comparability. Immunoassay platforms can yield different absolute values than LC-MS/MS, which offers higher specificity. Comparing results across different labs or methods can introduce apparent changes that are analytical rather than biological.
• Draw timing is less critical than for cortisol given DHEA-S's minimal diurnal swing, but many clinicians standardize morning draws for consistency across serial measurements.

DHEA-S and its companion hormone markers

DHEA-S is most informative when read alongside the markers that share its pathway or modify its downstream effects:

• Cortisol — the cortisol/DHEA-S ratio maps adrenal stress balance; low DHEA-S with high cortisol signals a catabolic, stress-skewed pattern rather than healthy adrenal output.
• Cortisol-to-DHEA-S ratio — directly tracks the stress-to-resilience axis; a rising ratio over time is more informative than either marker alone.
• Testosterone (total) — in women, high testosterone with elevated DHEA-S suggests a mixed adrenal contribution; high testosterone with normal DHEA-S points toward ovarian sources.
• Sex hormone-binding globulin (SHBG) — SHBG modifies how much testosterone is free to act; when DHEA-S is high and SHBG is low, androgenic symptoms may be more pronounced despite a modest absolute testosterone level.
• 17-hydroxyprogesterone — the key marker for congenital adrenal hyperplasia workups; elevated DHEA-S with high 17-OHP after stimulation testing supports an enzymatic block in the adrenal steroidogenesis pathway.

Why DHEA-S moves slowly between repeat tests

DHEA-S has a long half-life (approximately 10 hours) and circulates in a large sulfate pool that buffers acute shifts. Day-to-day variation is low, which is one of its strengths as a marker — but it also means that meaningful biological change takes time to register. The age-related decline is real but gradual; quarterly retesting in a stable adult typically measures noise rather than biology.

For most adults, annual testing is sufficient to establish and monitor a baseline. More frequent retesting — every 4–6 months — may be appropriate when evaluating the effect of a glucocorticoid medication, during a supervised DHEA supplementation trial, or when investigating hormonal symptoms alongside cortisol trends.

Consistency matters more than frequency. Using the same lab and the same assay method across serial draws allows meaningful trend comparison; switching platforms can introduce apparent changes that reflect analytical differences rather than any shift in adrenal output.

When DHEA-S warrants a clinical conversation

A one-time DHEA-S result is a snapshot; a series is a storyline. The clearest signals worth bringing to a clinician include: a persistently elevated result — particularly with symptoms such as acne, hirsutism, or irregular cycles — that warrants evaluation for PCOS, congenital adrenal hyperplasia, or an adrenal source; a very high value that does not normalize on repeat testing, which may prompt imaging; and a low or declining result in the context of fatigue, low libido, or reduced stress tolerance, especially alongside low cortisol, which may point to adrenal insufficiency or pituitary dysfunction.

Medication context matters: if you are on glucocorticoids or hormonal contraceptives, expect DHEA-S to be suppressed — that is a pharmacologic effect, not necessarily a disease signal, but it is worth tracking. Similarly, if you are using OTC DHEA supplements, disclose this before testing, as it will raise DHEA-S and can obscure the underlying picture.

Testing pairs best with context. Tracking symptoms, training load, sleep patterns, and medication changes alongside serial labs moves the conversation from a single number to a pattern — and from reacting to anticipating. A comprehensive panel that brings DHEA-S together with cortisol, sex hormones, metabolic markers, and inflammation signals gives a fuller view of the system at once. Superpower is built around that approach; you can read more about it at our manifesto.